ReWalk Robotics soars after medical device gets FDA breakthrough designation

Lifeward

05/11/2021 12:44

** Shares of medical device maker  RWLK.O  up ~51% at $1.95
premarket - a top performer across stock indices
    ** Co's ReBoot device on Thursday received breakthrough
device designation by FDA  urn:newsml:reuters.com:*:nGNX3KDC49 
    ** Designation is given to certain medical devices and
device-led combination products that provide for more effective
treatment or diagnosis of life-threatening or irreversibly
debilitating diseases or conditions
    ** Co's ReBoot device, which received FDA clearance in 2019
for use in rehabilitation setting, is a robotic suit that helps
people with reduced ankle function related to neurological
injuries like stroke, to walk
    ** Up to Thursday's close, stock had fallen 2.27% YTD 

 (Reporting by Oishee Majumdar in Bengaluru)
 ((oishee.majumdar@thomsonreuters.com;))